← All stocks

NextCure, Inc.

NXTC Net buying
CIK 0001661059 #4911 in the set updated 17 Sep 2026
Bought (120 mo)
$27.10M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$184.80K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$184.80K
1 of 1 sales
Net
+$26.91M
+$26.91M against sales at will

By person

11 insiders · 24 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sofinnova Venture Partners IX, L.P. entity
10% owner
$11.51M (2)
+$11.51M
2,671,856
$16.46M
Khuong Chau Quang
Director
$5.25M (1)
+$5.25M
2,711,013
$16.70M
ORBIMED ADVISORS LLC entity
Director
$5.25M (1)
+$5.25M
2,711,013
$16.70M
Xu Stella
Director
$1.88M (1)
+$1.88M
1,103,570
$6.80M
ADAR1 Capital Management, LLC entity
10% owner
$1.71M (13)
+$1.71M
722,419
$4.45M
+92.3%
CANAAN X L.P.
10% owner
$750.00K (1)
+$750.00K
2,254,442
$13.89M
SHANNON TIMOTHY M
Director
$750.00K (1)
+$750.00K
2,254,442
$13.89M
Simcere Zaiming, Inc. entity
Former 10% Owner
$184.80K (1)
−$184.80K
308,636
$1.90M
−8.9%
Alexandria Venture Investments, LLC entity
10% owner
197,993
$1.22M
Liu Linda
SVP, Research
55,234
$340.24K
Heller Kevin N.
Chief Medical Officer
49,011
$301.91K
+125.0%

No percentages here. This company's share count has moved by a factor of 10.5 over the window, from 2,676,110 to 28,050,191 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Simcere Zaiming, Inc.
10 Aug 2026
Former 10% Owner
Sell indirect
30,000
$6.16
$184.80K
ADAR1 Capital Management, LLC
31 Jul 2026
10% owner
Buy indirect
8,003
$4.80
$38.41K
ADAR1 Capital Management, LLC
31 Jul 2026
10% owner
Buy indirect
25,000
$4.98
$124.54K
ADAR1 Capital Management, LLC
31 Jul 2026
10% owner
Buy indirect
3,300
$4.98
$16.42K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
77,850
$4.96
$385.79K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
100,000
$4.90
$490.00K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
25,000
$4.81
$120.34K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
20,000
$5.00
$100.00K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
20,000
$5.00
$100.00K
ADAR1 Capital Management, LLC
30 Jul 2026
10% owner
Buy indirect
50,000
$4.97
$248.62K
ADAR1 Capital Management, LLC
29 Jul 2026
10% owner
Buy indirect
1,600
$5.00
$8.00K
ADAR1 Capital Management, LLC
29 Jul 2026
10% owner
Buy indirect
1,810
$5.00
$9.05K
ADAR1 Capital Management, LLC
28 Jul 2026
10% owner
Buy indirect
6,400
$4.95
$31.68K
ADAR1 Capital Management, LLC
27 Jul 2026
10% owner
Buy indirect
7,798
$5.00
$38.99K
Heller Kevin N.
14 Jul 2020
Chief Medical Officer
Exercised, kept
27,229
$1.77
$48.20K
Liu Linda
27 Nov 2019
SVP, Research
Exercised, kept
20,745
$1.21
$25.10K
Liu Linda
27 Nov 2019
SVP, Research
Exercised, kept
34,489
$0.48
$16.55K
Sofinnova Venture Partners IX, L.P.
15 Nov 2019
10% owner
Buy
150,000
$36.75
$5.51M
ORBIMED ADVISORS LLC
13 May 2019
Director
Buy indirect
350,000
$15.00
$5.25M
CANAAN X L.P.
13 May 2019
10% owner
Buy
50,000
$15.00
$750.00K
Xu Stella
13 May 2019
Director
Buy indirect
125,000
$15.00
$1.88M
Khuong Chau Quang
13 May 2019
Director
Buy indirect
350,000
$15.00
$5.25M
SHANNON TIMOTHY M
13 May 2019
Director
Buy indirect
50,000
$15.00
$750.00K
Sofinnova Venture Partners IX, L.P.
13 May 2019
10% owner
Buy
400,000
$15.00
$6.00M

What was left out

Form 4 filings counted 127
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 12,511,792
History held since 13 May 2019